$3.68
0.319.2%
Last update: Nov 6, 7:05 PM
Immuneering Corp
IMRXNASDAQ
The average analyst price target for Immuneering is $15.13, 319.1% above the current price. Of 10 analysts, 7 rate it Buy and 3 Hold. Targets range from $3 to $30. The latest change came on Aug 6, 2026, when HC Wainwright & Co. initiated coverage of Immuneering with a Buy rating and a $14 price target.
Price Target Range — 12 Quarters
Analyst Consensus — 10 Analysts
Rating Trend — Last 9 Months
